IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Socma Testifies on Risks Involving Pharma Ingredient Imports

2:40 PM MST | November 7, 2007 | Chemical Week Editorial Staff

Socma’s bulk pharmaceutical task force chief John Dubeck testified last week at a House Energy & Commerce Committee’s subcommittee on oversight and investigation about risks associated with drugs imported into the U.S. There is a lack of government inspections of overseas facilities manufacturing active pharma ingredients (APIs) that go into drugs, Dubeck says. The majority of overseas facilities manufacturing APIs used in generic medications rarely see an FDA inspector after an initial inspection, and most overseas manufacturers of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa